 |
 |
| 1. |
Goh AS, Chung AY, Lo RH, Lau TN, Yu SW, Chng M, Satchithanantham S, Loong SL, Ng DC, Lim BC, Conor S, Chow PK. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous 32 (32P) brachytherapy delivery device - a first-in-man study. Int J Radiat Oncol Biol Phys 2007; 67:786-92 |
| 2. |
Zhang K, Loong SL, Connor S, Yu SW, Tan SY, Ng RT, Lee KM, Canham L and *Chow PK , Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice. Clin Cancer Res , 2005. 11 (20): p. 7532-7. |
| 3. |
Chow PK , Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma. Cancer Treat Rev , 2005. 6. : p. 491-5. |
| 4. |
Nowak AK, Stockler MR, Chow PK, Findlay M. Use of tamoxifen in advanced-stage hepatocellular carcinoma. Cancer 2005 Apr 1;103(7):1408-14. |
| 5. |
Zhang K, Chow PK. The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo. Clin Cancer Res 2004;10 5226-5232. |
| 6. |
Nowak A, Chow PK, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Europ J Cancer 40(10):1474-84, 2004. |
| 7. |
Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, Soo KC. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multi-center randomized controlled trial. Hepatology 2002 Nov;36(5):1221-1226
|
| 8. |
Chow PK, Hung H, Soo KC. Estrogen receptor status in inoperable hepatocellular carcinoma. Am J Gastroenterol 2001 96:1297-8. |
| 9 |
Tan CK, Chow PK, Findlay M, Wong C, Machin D Use of tamoxifen in hepatocellular carcinoma: A review and paradigm shift. J Gastroenterol Hepatol 2000 15:725-29. |
| 10 |
Chow PK, Soo KC. Hormonal therapy in Hepatocellular Carcinoma: The current scientific and clinical evidence. Asian J Surg 2000 23(1):56-63. |
| 11 |
Chan E, Chow PK, Tai BC, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. Cochrane Database Syst Rev. 2000 2:CD001199.
|
| 12 |
Chow P, Tan CK, Tai BC, Machin D. Tamoxifen in Hepatocellular Carcinoma. Lancet 1998 352:819-820. |
|
|
|
